ERBB2 and breast carcinoma: Based on immunohistochemistry analysis, breast cancer can be classified into three distinct molecular subtypes, including estrogen or progesterone receptor positive (ER+/PR+), human epidermal growth factor receptor positive (HER2+), and triple-negative (TNBC) (4, 5).